No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
High Growth Tech Stocks Including Arcturus Therapeutics Holdings And Two Others
Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Madrigal Pharmaceuticals (MDGL)
Arcturus Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co.
Arcturus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Cantor Fitzgerald Reiterates Overweight on Arcturus Therapeuticsto Overweight
Arcturus Therapeutics Analyst Ratings